The report suggests that these manufacturers include consumer goods companies such as Hamdard Laboratories, Dabur and Sri Sri Tattva. They have also registered for trials of their drugs which they expect to boost immunity against COVID-19 — the disease caused by the novel coronavirus.
The newspaper report cites company executives as saying that these trials will be conducted on asymptomatic and suspected COVID-19 patients. These trials are to test the efficacy of immunity boosters in preventing and curing patients.
Results from these trials are expected to be announced in two months.
Read more: Trials with Ayurvedic, Homeopathy and Unani
Disclaimer: Apta Ayurveda doesn’t verify the above report.
Apta Ayurveda 